HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 18MG

Identification of Hydromorph Contin-Controlled Release Cap - 18Mg

No description

Google image searchProduct monograph

Active ingredient

hydromorphone hydrochloride, 18 MG

DIN: 02243562

Dosage form(s): CAPSULE (SUSTAINED-RELEASE)

Route(s) of administration: ORAL

Schedule: Narcotic (CDSA I)

Company: PURDUE PHARMA

Date: 03-JUL-2001

ATC:

• N02 — ANALGESICS (ATC, ATC/DDD, )
• N02A — OPIOIDS (ATC, ATC/DDD)
• N02AA — Natural opium alkaloids (ATC, ATC/DDD)
• N02AA03 — HYDROMORPHONE (ATC/DDD)

Reference brand drug: Dilaudid, Jurnista

Pharmaceutical standard: USP

External Links for Hydromorph Contin-Controlled Release Cap - 18Mg

Search on Google

• Hydromorph Contin-Controlled Release Cap - 18Mg side effects
• Hydromorph Contin-Controlled Release Cap - 18Mg dosage
• hydromorphone hydrochloride side effects
• hydromorphone hydrochloride dosage

Purdue Pharma

Go to Purdue website to see drug product details. Sometimes you can find hydromorph contin-controlled release cap - 18mg photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.